Back to companies

BioNTech SE

BNTXDENASDAQPharmaceuticals & Healthcare

BioNTech SE

Revenue
€2.9bn
YoY +4.3%
Operating income
-€1.4bn
FY2025
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API